NYLIM
REGN icon

New York Life Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

New York Life Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
16,588
-229
-1% -$156K 0.07% 219
2026
Q1 		$13M Buy
16,817
+1,730
+11% +$1.32M 0.11% 160
2025
Q4 		$11.6M Buy
15,087
+1,144
+8% +$777K 0.1% 171
2025
Q3 		$7.84M Sell
13,943
-410
-3% -$232K 0.07% 245
2025
Q2 		$7.54M Buy
14,353
+113
+0.8% +$63.1K 0.07% 244
2025
Q1 		$9.03M Sell
14,240
-64
-0.4% -$44K 0.09% 201
2024
Q4 		$10.2M Buy
14,304
+55
+0.4% +$46.2K 0.1% 185
2024
Q3 		$15M Sell
14,249
-407
-3% -$453K 0.15% 141
2024
Q2 		$15.4M Buy
14,656
+132
+0.9% +$128K 0.15% 134
2024
Q1 		$14M Sell
14,524
-765
-5% -$727K 0.14% 141
2023
Q4 		$13.4M Sell
15,289
-2,935
-16% -$2.42M 0.14% 144
2023
Q3 		$15M Sell
18,224
-496
-3% -$390K 0.16% 127
2023
Q2 		$13.5M Buy
18,720
+65
+0.3% +$50.1K 0.14% 143
2023
Q1 		$15.3M Sell
18,655
-991
-5% -$747K 0.17% 131
2022
Q4 		$14.2M Sell
19,646
-93
-0.5% -$68.6K 0.16% 145
2022
Q3 		$13.6M Sell
19,739
-319
-2% -$201K 0.16% 136
2022
Q2 		$11.9M Buy
+20,058
New +$13M 0.14% 157

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

New York Life Investment Management's REGN Position: Q2 2026 in Review

New York Life Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, selling an estimated $156K and leaving 16,588 shares worth $10.3M. The position accounts for 0.07% of the portfolio, ranked #219.

New York Life Investment Management first reported a position in REGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $15.4M in Q2 2024. 959 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • New York Life Investment Management held 16,588 shares of Regeneron Pharmaceuticals worth $10.3M as of Q2 2026.
  • New York Life Investment Management sold 229 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $156K.
  • Regeneron Pharmaceuticals made up 0.07% of New York Life Investment Management's portfolio in Q2 2026, its #219 holding.
  • New York Life Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Regeneron Pharmaceuticals position peaked at $15.4M in Q2 2024.
  • 959 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.